1. Remick DG. Pathophysiology of sepsis. Am J Pathol 
2007;170:1435‑44.
2. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Rapid 
increase in hospitalization and mortality rates for severe sepsis 
in the United States: A trend analysis from 1993 to 2003. Crit 
Care Med 2007;35:1244‑50.
3. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, 
Opal SM, et al. Surviving sepsis campaign: International 
guidelines for management of severe sepsis and septic shock, 
2012. Intensive Care Med 2013;39:165‑228.
4. Angus DC, van der Poll T. Severe sepsis and septic shock. 
N Engl J Med 2013;369:840‑51.
5. Vasu TS, Cavallazzi R, HiraniA, Kaplan G, Leiby B, Marik PE. 
Norepinephrine or dopamine for septic shock: Systematic 
review of randomized clinical trials. J Intensive Care Med 
2012;27:172‑8.
6. Landry DW, Levin HR, Gallant EM, Seo S, D’Alessandro D, 
Oz MC, et al. Vasopressin pressor hypersensitivity in 
vasodilatory septic shock. Crit Care Med 1997;25:1279‑82.
7. Sharshar T, Carlier R, Blanchard A, Feydy A, Gray F, 
Paillard M, et al. Depletion of neurohypophyseal content of 
vasopressin in septic shock. Crit Care Med 2002;30:497‑500.
8. Petros A, Bennett D, Vallance P. Effect of nitric oxide synthase 
inhibitors on hypotension in patients with septic shock. Lancet 
1991;338:1557‑8.
9. PetrosA, Lamb G, LeoneA, Moncada S, Bennett D, Vallance P. 
Effects of a nitric oxide synthase inhibitor in humans with 
septic shock. Cardiovasc Res 1994;28:34‑9.
10. Preiser JC, Lejeune P, Roman A, Carlier E, De Backer D, 
Leeman M, et al. Methylene blue administration in septic 
shock: A clinical trial. Crit Care Med 1995;23:259-64.
11. O’Brien A, Clapp L, Singer M. Terlipressin for 
norepinephrine‑resistant septic shock. Lancet 2002;359:1209‑10.
12. Carr A, Frei B. Does Vitamin C act as a pro‑oxidant under 
physiological conditions? FASEB J 1999;13:1007‑24.
13. Carr AC, Frei B. Toward a new recommended dietary 
allowance for Vitamin C based on antioxidant and health 
effects in humans. Am J Clin Nutr 1999;69:1086‑107.
14. Hunt C, Chakravorty NK, Annan G, Habibzadeh N, 
Schorah CJ. The clinical effects of Vitamin C supplementation 
in elderly hospitalised patients with acute respiratory 
infections. Int J Vitam Nutr Res 1994;64:212‑9.
15. Fowler AA 3rd, SyedAA, Knowlson S, SculthorpeR, FarthingD, 
DeWilde C, et al. Phase I safety trial of intravenous ascorbic 
acid in patients with severe sepsis. J Transl Med 2014;12:32.
16. Schorah CJ, Downing C, Piripitsi A, Gallivan L, Al-Hazaa AH, 
Sanderson MJ, et al. Total Vitamin C, ascorbic acid, and 
dehydroascorbic acid concentrations in plasma of critically 
ill patients. Am J Clin Nutr 1996;63:760-5.
17. Tanaka H, Matsuda T, Miyagantani Y, Yukioka T, Matsuda H, 
Shimazaki S. Reduction of resuscitation fluid volumes in 
severely burned patients using ascorbic acid administration: 
A randomized, prospective study. Arch Surg 2000;135:326‑31.
18. Nathens AB, Neff MJ, Jurkovich GJ, Klotz P, Farver K, Ruzinski JT, et al. Randomized, prospective trial of antioxidant 
supplementation in critically ill surgical patients. Ann Surg 
2002;236:814‑22.
19. Wilson JX. Evaluation of Vitamin C for adjuvant sepsis 
therapy. Antioxid Redox Signal 2013;19:2129‑40.
20. Oudemans‑van Straaten HM, Spoelstra‑de Man A, de 
Waard MC. Vitamin C revisited. Crit Care Med 2014;18:460.
21. Riordan HD, Hunninghake RB, Riordan NH, Jackson JJ, 
Meng X, Taylor P, et al. Intravenous ascorbic acid: Protocol 
for its application and use. P R Health Sci J 2003;22:287‑90.
22. Hoffer LJ, Levine M, Assouline S, Melnychuk D, Padayatty SJ, 
Rosadiuk K, et al. Phase I clinical trial of i.v. ascorbic acid in 
advanced malignancy. Ann Oncol 2008;19:1969‑74.
23. Mak S, Newton GE. Vitamin C augments the inotropic 
response to dobutamine in humans with normal left 
ventricular function. Circulation 2001;103:826‑30.
24. Nooraee N, Fathi M, Edalat L, Behnaz F, Mohajerani SA, 
Dabbagh A. Effect of Vitamin C on serum cortisol reduction 
after etomidate induction of anesthesia. J Cell Mol Anesth 
2015;1:28‑33.
25. Kieffer P, Thannberger P, Wilhelm JM, Kieffer C, Schneider F. 
Multiple organ dysfunction dramatically improving with the 
infusion of Vitamin C: More support for the persistence of 
scurvy in our “welfare” society. Intensive Care Med 2001;27:448.
26. Zipursky JS, Alhashemi A, Juurlink D. A rare presentation 
of an ancient disease: Scurvy presenting as orthostatic 
hypotension. BMJ Case Rep 2014;2014. pii: Bcr2013201982.
27. Holley AD, Osland E, Barnes J, Krishnan A, Fraser JF. Scurvy: 
Historically a plague of the sailor that remains a consideration 
in the modern intensive care unit. Intern Med J 2011;41:283‑5.
28. Long CL, Maull KI, Krishnan RS, Laws HL, Geiger JW, 
Borghesi L, et al. Ascorbic acid dynamics in the seriously ill 
and injured. J Surg Res 2003;109:144‑8.
29 Fukushima R, Yamazaki E. Vitamin C requirement in surgical 
patients. Curr Opin Clin Nutr Metab Care 2010;13:669-76.
30. Crandon JH, Landau B, Mikal S, Balmanno J, Jefferson M, 
Mahoney N. Ascorbic acid economy in surgical patients 
as indicated by blood ascorbic acid levels. N Engl J Med 
1958;258:105‑13.
31. Kirkemo AK, Burt ME, Brennan MF. Serum Vitamin level 
maintenance in cancer patients on total parenteral nutrition. 
Am J Clin Nutr 1982;35:1003‑9.
32. Lowry SF, Goodgame JT Jr., Maher MM, Brennan MF. 
Parenteral Vitamin requirements during intravenous feeding. 
Am J Clin Nutr 1978;31:2149‑58.
33. De Backer D, Scolletta S. Clinical management of the 
cardiovascular failure in sepsis. Curr Vasc Pharmacol 
2013;11:222‑42.
34. Hornig D. Distribution of ascorbic acid, metabolites 
and analogues in man and animals. Ann N Y Acad Sci 
1975;258:103‑18.
35. May JM, Qu ZC, Nazarewicz R, Dikalov S. Ascorbic acid 
efficiently enhances neuronal synthesis of norepinephrine 
from dopamine. Brain Res Bull 2013;90:35‑42.
36. Levine M. Ascorbic acid specifically enhances dopamine 
beta‑monooxygenase activity in resting and stimulated 
chromaffin cells. J Biol Chem 1986;261:7347‑56.
37. Deana R, Bharaj BS, Verjee ZH, Galzigna L. Changes relevant 
to catecholamine metabolism in liver and brain of ascorbic acid 
deficient guinea‑pigs. Int J Vitam Nutr Res 1975;45:175‑82.
38. Hoehn SK, Kanfer JN. Effects of chronic ascorbic acid 
deficiency on guinea pig lysosomal hydrolase activities. J Nutr 
1980;110:2085‑94.
39. Bornstein SR, Yoshida‑Hiroi M, Sotiriou S, Levine M, 
Hartwig HG, Nussbaum RL, et al. Impaired adrenal 
catecholamine system function in mice with deficiency of the 
ascorbic acid transporter (SVCT2). FASEB J 2003;17:1928‑30.
40. Duggan M, Browne I, Flynn C. Adrenal failure in the critically 
ill. Br J Anaesth 1998;81:468‑70.
41. Nieboer P, van der Werf TS, Beentjes JA, Tulleken JE, 
Zijlstra JG, Ligtenberg JJ. Catecholamine dependency in a 
polytrauma patient: Relative adrenal insufficiency? Intensive 
Care Med 2000;26:125‑7.
42. Treschan TA, Peters J. The vasopressin system: Physiology 
and clinical strategies. Anesthesiology 2006;105:599‑612.
43. Russell JA. Bench‑to‑bedside review: Vasopressin in the 
management of septic shock. Crit Care Med 2011;15:226.
44. Sharshar T, Blanchard A, Paillard M, Raphael JC, Gajdos P, 
Annane D. Circulating vasopressin levels in septic shock. Crit 
Care Med 2003;31:1752‑8.
45. Prigge ST, Mains RE, Eipper BA, Amzel LM. New insights into 
copper monooxygenases and peptide amidation: Structure, 
mechanism and function. Cell Mol Life Sci 2000;57:1236‑59.
46. Landry DW, Levin HR, Gallant EM, Ashton RC Jr., Seo S, 
D’Alessandro D, et al. Vasopressin deficiency contributes to 
the vasodilation of septic shock. Circulation 1997;95:1122‑5.
47. Giusti‑Paiva A, Domingues VG. Centrally administered 
ascorbic acid induces antidiuresis, natriuresis and 
neurohypophyseal hormone release in rats. Neuro Endocrinol 
Lett 2010;31:87‑91.
48. Kahn SA, Beers RJ, Lentz CW. Resuscitation after severe burn 
injury using high‑dose ascorbic acid: A retrospective review. 
J Burn Care Res 2011;32:110‑7.
49. Morelli A, Ertmer C, Rehberg S, Lange M, Orecchioni A, 
Laderchi A, et al. Phenylephrine versus norepinephrine 
for initial hemodynamic support of patients with septic 
shock: A randomized, controlled trial. Crit Care Med 
2008;12:R143.